Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Open in Screener

BVS

Bioventus Inc

Feb 12 • 12:37PM ET

8.18

+0.10 1.29 %

Healthcare • Medical Devices • USA • NASD

Peers: ZBH SNN GMED IART XRAY OFIX BAX CNMD PODD MEDP

| Held by: IWM VTI AVUV VXF IWO FESM SCHA VTWO DFAS IWC

Index	RUT	P/E	72.88	EPS (ttm)	0.11	Insider Own	31.32%	Shs Outstand	66.97M	Perf Week	-0.32%
Market Cap	677.34M	Forward P/E	10.45	EPS next Y	0.78	Insider Trans	-0.11%	Shs Float	46.00M	Perf Month	6.29%
Enterprise Value	1.02B	PEG	0.48	EPS next Q	0.22	Inst Own	54.95%	Short Float	3.36%	Perf Quarter	6.29%
Income	7.82M	P/S	1.20	EPS this Y	34.99%	Inst Trans	0.15%	Short Ratio	5.57	Perf Half Y	8.69%
Sales	563.83M	P/B	3.30	EPS next Y	18.41%	ROA	1.06%	Short Interest	1.55M	Perf YTD	10.00%
Book/sh	2.48	P/C	16.07	EPS next 5Y	21.67%	ROE	4.97%	52W High	11.25 -27.25%	Perf Year	-20.31%
Cash/sh	0.51	P/FCF	12.67	EPS past 3/5Y	- -113.92%	ROIC	1.59%	52W Low	5.81 40.86%	Perf 3Y	373.06%
Dividend Est.	-	EV/EBITDA	10.63	Sales past 3/5Y	9.98% 11.00%	Gross Margin	66.66%	Volatility	5.94% 4.23%	Perf 5Y	-52.47%
Dividend TTM	-	EV/Sales	1.80	EPS Y/Y TTM	118.96%	Oper. Margin	8.51%	ATR (14)	0.37	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	1.14	Sales Y/Y TTM	1.58%	Profit Margin	1.39%	RSI (14)	55.10	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.74	EPS Q/Q	161.98%	SMA20	1.51%	Beta	0.79	Target Price	14.50
Payout	-	Debt/Eq	2.05	Sales Q/Q	-0.23%	SMA50	5.62%	Rel Volume	0.57	Prev Close	8.08
Employees	930	LT Debt/Eq	1.96	Earnings	Nov 04 BMO	SMA200	15.07%	Avg Volume	277.58K	Price	8.18
IPO	Feb 11, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	43.27% 0.34%	Trades		Volume	80,244	Change	1.29%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-09-26	Initiated	Barrington Research	Outperform	$13
Jul-07-25	Initiated	Cantor Fitzgerald	Overweight	$12
Dec-17-24	Upgrade	JP Morgan	Underweight → Neutral	$12 → $13
Dec-07-23	Upgrade	Canaccord Genuity	Hold → Buy	$7
Aug-09-23	Upgrade	Craig Hallum	Hold → Buy	$4 → $6
Nov-22-22	Downgrade	Craig Hallum	Buy → Hold
Nov-09-22	Downgrade	JP Morgan	Overweight → Underweight
Nov-09-22	Downgrade	Canaccord Genuity	Buy → Hold	$18 → $6
Mar-15-22	Initiated	Craig Hallum	Buy	$30
Nov-15-21	Resumed	Morgan Stanley	Overweight	$20
Nov-10-21	Resumed	JP Morgan	Overweight	$25
Jul-01-21	Downgrade	Goldman	Buy → Neutral	$20 → $19
Mar-08-21	Initiated	Morgan Stanley	Overweight	$18
Mar-08-21	Initiated	JP Morgan	Overweight	$17
Mar-08-21	Initiated	Goldman	Buy	$19
Mar-08-21	Initiated	Canaccord Genuity	Buy	$23

Show Previous Ratings

Jan-15-26 07:55PM	Bioventus Details Turnaround Plan, Four Growth Drivers at J.P. Morgan Conference (MarketBeat)
Jan-06-26 07:30AM	Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-05-25 03:30PM	HALPER SADEH LLC ENCOURAGES BIOVENTUS INC. SHAREHOLDERS TO CONTACT THE FIRM TO DISCUSS THEIR RIGHTS (PR Newswire) -6.96%
Nov-25-25 04:15PM	Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire) +5.13%
Nov-04-25 04:08PM	Bioventus Inc (BVS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com) +15.09%
07:44AM	Loading…
07:44AM	Bioventus: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Reports Third Quarter Financial Results (GlobeNewswire)
Nov-03-25 08:02AM	What To Expect From Bioventus Inc (BVS) Q3 2025 Earnings (GuruFocus.com)
Oct-28-25 07:00AM	Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 (GlobeNewswire)
Oct-22-25 07:08PM	Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights (Business Wire)
Sep-03-25 07:30AM	Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire)
Aug-13-25 12:08PM	Craig-Hallum Reiterates a Buy Rating on Bioventus (BVS), Sets a $15 PT (Insider Monkey)
Aug-07-25 04:15PM	Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference (GlobeNewswire)
Aug-06-25 08:55AM	Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates (Zacks) +18.73%
07:52AM	Bioventus: Q2 Earnings Snapshot (Associated Press Finance)
07:00AM	Loading…
07:00AM	Bioventus Reports Second Quarter Financial Results (GlobeNewswire)
Aug-05-25 10:18AM	What To Expect From Bioventus Inc (BVS) Q2 2025 Earnings (GuruFocus.com)
Aug-04-25 08:00AM	Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity (GlobeNewswire)
Jul-30-25 07:30AM	Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products (GlobeNewswire)
Jul-29-25 04:15PM	Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025 (GlobeNewswire)
Jul-16-25 09:39AM	Cantor Fitzgerald Initiates Coverage of Bioventus (BVS) with an Overweight Rating (Insider Monkey)
Jun-13-25 08:30AM	Do Options Traders Know Something About Bioventus Stock We Don't? (Zacks)
May-07-25 03:09AM	Bioventus Inc (BVS) Q1 2025 Earnings Call Highlights: Navigating Growth Amidst Divestitures (GuruFocus.com) +6.29%
01:21AM	Q1 2025 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents)
May-06-25 08:45AM	Bioventus (BVS) Q1 Earnings and Revenues Surpass Estimates (Zacks) -11.81%
07:50AM	Bioventus: Q1 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
May-05-25 10:10AM	Bioventus Inc (BVS) Q1 2025 Earnings Report Preview: What To Look For (GuruFocus.com)
Apr-28-25 08:00AM	Bioventus to Report First Quarter of Fiscal Year 2025 Financial Results on May 6, 2025 (GlobeNewswire)
Apr-24-25 01:25AM	Artisan Sustainable Emerging Markets Fund Q1 2025 Commentary (Seeking Alpha)
08:21AM	Loading…
Apr-17-25 08:21AM	4 Healthcare Stocks to Buy as the Sector Faces Government Heat (Zacks)
Apr-03-25 01:09PM	Ensign Group Invests in Growth With New Facility Acquisitions (Zacks)
Mar-31-25 09:55AM	Here's Why Bioventus (BVS) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Mar-28-25 11:06AM	Centene & HMHB Hawaii Expand Partnership for Maternal Care (Zacks)
Mar-17-25 12:00PM	Bioventus (BVS) Upgraded to Buy: Here's What You Should Know (Zacks)
Mar-12-25 03:08AM	Q4 2024 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) -6.76%
03:04AM	Bioventus Inc (BVS) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Debt ... (GuruFocus.com)
Mar-11-25 08:45AM	Bioventus (BVS) Q4 Earnings and Revenues Surpass Estimates (Zacks) +23.29%
07:52AM	Bioventus: Q4 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Announces Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-28-25 07:30AM	Bioventus to Report Fourth Quarter of Fiscal Year 2024 Financial Results on March 11, 2025 (GlobeNewswire)
Jan-07-25 08:00AM	Bioventus to Present at the 43rd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Jan-03-25 08:05AM	Bioventus completes divestiture of its Advanced Rehabilitation business (TipRanks)
Jan-02-25 08:00AM	Bioventus Completes Divestiture of its Advanced Rehabilitation Business to Accelmed Partners (GlobeNewswire)
Dec-23-24 09:40AM	Is Bioventus (BVS) Outperforming Other Medical Stocks This Year? (Zacks)
Dec-06-24 09:55AM	Wall Street Analysts Think Bioventus (BVS) Could Surge 26.03%: Read This Before Placing a Bet (Zacks)
Nov-06-24 02:43AM	Q3 2024 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents)
02:14AM	Bioventus Inc (BVS) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Raised Guidance ... (GuruFocus.com)
Nov-05-24 08:45AM	Bioventus (BVS) Matches Q3 Earnings Estimates (Zacks) -16.27%
07:41AM	Bioventus: Q3 Earnings Snapshot (Associated Press Finance)
07:30AM	Bioventus Reports Third Quarter Financial Results (GlobeNewswire)
Nov-04-24 09:40AM	Are Medical Stocks Lagging Bioventus (BVS) This Year? (Zacks)
07:09AM	Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Oct-29-24 07:30AM	Bioventus to Report Third Quarter of Fiscal Year 2024 Financial Results on November 5, 2024 (GlobeNewswire)
Oct-15-24 04:01PM	Solventum Stock Earns 81 RS Rating (Investor's Business Daily)
Oct-09-24 05:03PM	Bioventus Inc (BVS) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com)
Oct-01-24 09:00AM	Bioventus Announces Divestiture of its Advanced Rehabilitation Business to Accelmed Partners (GlobeNewswire)
Aug-29-24 07:09AM	Bull Of The Day: Bioventus (BVS) (Zacks)
Aug-07-24 04:15PM	Bioventus to Present at the Canaccord Genuity 44th Annual Global Growth Conference (GlobeNewswire) -7.79%
Aug-06-24 07:30AM	Bioventus Reports Second Quarter Financial Results (GlobeNewswire) +29.23%
Jul-30-24 07:30AM	Bioventus to Report Second Quarter of Fiscal Year 2024 Financial Results on August 6, 2024 (GlobeNewswire)
Jun-05-24 10:17AM	Here's Why You Should Consider Buying Bioventus (BVS) Stock (Zacks)
May-23-24 06:42AM	3 Stocks Under $10 With Mammoth Growth Prospects (InvestorPlace)
May-09-24 07:29AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday (InvestorPlace) +8.33%
May-08-24 12:28PM	Bioventus Inc. (NASDAQ:BVS) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:19AM	Bioventus Inc (BVS) Q1 2024 Earnings Call Transcript Highlights: Strong Start with Significant ... (GuruFocus.com)
May-07-24 11:41PM	Q1 2024 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +28.00%
07:00AM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
Apr-29-24 07:30AM	Bioventus to Report First Quarter of Fiscal Year 2024 Financial Results on May 7, 2024 (GlobeNewswire)
Mar-13-24 08:48AM	Bioventus Inc. (NASDAQ:BVS) Q4 2023 Earnings Call Transcript (Insider Monkey) -5.54%
Mar-12-24 10:20PM	Q4 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +5.46%
09:11AM	Bioventus Inc (BVS) Reports Growth in Q4 Sales and Adjusted EBITDA, Provides Optimistic 2024 ... (GuruFocus.com)
07:30AM	Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire)
Mar-04-24 08:00AM	Bioventus to Report Fourth Quarter of Fiscal Year 2023 Financial Results on March 12, 2024 (GlobeNewswire)
Jan-18-24 04:15PM	Bioventus Enters into an Amendment with its Credit Agreement Lenders to Enhance Financial and Operational Flexibility (GlobeNewswire)
Jan-12-24 04:15PM	Bioventus Announces Inducement Equity to President and Chief Executive Officer Robert Claypoole (GlobeNewswire)
Dec-19-23 04:30PM	Bioventus Names Robert Claypoole as President and Chief Executive Officer (GlobeNewswire)
Dec-06-23 08:00AM	Bioventus Agrees to Nationwide Contract with Aetna Medicare Advantage Plans for DUROLANE for Knee Osteoarthritis (GlobeNewswire)
Nov-27-23 01:33AM	Smith & Nephew inks $180M CartiHeal buyout, capitalizing on Bioventus turmoil to land knee implant (MedTech Dive)
Nov-12-23 09:02AM	Bioventus Inc. (NASDAQ:BVS) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-07-23 07:59AM	Bioventus Inc (BVS) Reports Q3 2023 Financial Results, Raises Full Year 2023 Financial Guidance (GuruFocus.com)
07:00AM	Bioventus Reports Third Quarter Financial Results; Raises Full Year 2023 Financial Guidance (GlobeNewswire)
Oct-31-23 07:00AM	Bioventus to Report Third Quarter of Fiscal Year 2023 Financial Results on November 7, 2023 (GlobeNewswire) +5.37%
Oct-25-23 10:48AM	Bioventus (BVS) to Report Q3 Earnings: What's in the Cards? (Zacks)
Sep-28-23 07:43AM	3 Value Medical Stocks to Buy for Safety Amid Market Volatility (Zacks)
Sep-19-23 09:52PM	Bioventus to Present at the Cantor Global Healthcare Conference (GlobeNewswire)
Sep-06-23 04:30PM	Bioventus to Present at the Morgan Stanley 21st Annual Global Healthcare Conference (GlobeNewswire)
Aug-16-23 09:02AM	Juniper Investment Company, LLC Increases Stake in Bioventus Inc (GuruFocus.com) -5.26%
Aug-10-23 08:09AM	Bioventus works to trim debt under interim CEO (American City Business Journals) +11.74%
Aug-08-23 10:02PM	Q2 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +14.12% +5.41%
07:30AM	Bioventus Reports Second Quarter Financial Results; Introduces Full Year 2023 Financial Guidance (GlobeNewswire)
Aug-04-23 08:30AM	Bioventus to Present at the Canaccord Genuity 43rd Annual Global Growth Conference (GlobeNewswire)
Aug-01-23 05:35PM	Bioventus to Report Second Quarter of Fiscal Year 2023 Financial Results on August 8, 2023 (GlobeNewswire)
Jun-23-23 06:35PM	Madrigal Pharmaceuticals and Bioventus Stock See Action From Activist Investors (Barrons.com) -7.02%
May-25-23 06:38AM	Daily Vickers Top Buyers & Sellers for 05/25/2023 (Argus Research)
May-23-23 07:30AM	Bioventus Completes Divestiture of its Wound Business (GlobeNewswire) +16.27%
May-18-23 12:07PM	Bioventus Inc. (NASDAQ:BVS) Q1 2023 Earnings Call Transcript (Insider Monkey) +11.45%
May-17-23 08:33AM	Q1 2023 Bioventus Inc Earnings Call (Thomson Reuters StreetEvents) +9.17%
May-16-23 04:15PM	Bioventus Reports First Quarter Financial Results (GlobeNewswire)
May-15-23 05:33PM	Bioventus Reschedules Reporting of First Quarter Fiscal Year 2023 Financial Results to After Market Close on May 16, 2023 (GlobeNewswire)

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Claypoole Robert E	President and CEO	Jan 09 '26	Option Exercise	0.00	93,750	0	158,714	Jan 13 05:30 PM
NOHRA GUY P	Director	Dec 04 '25	Sale	7.57	10,000	75,658	116,610	Dec 08 05:02 PM
NOHRA GUY P	Director	Dec 04 '25	Proposed Sale	7.57	10,000	75,658		Dec 04 01:54 PM
McMurry-Heath Michelle	Director	Nov 07 '25	Sale	7.42	17,701	131,255	56,997	Nov 10 05:08 PM
McMurry-Heath Michelle	Director	Nov 07 '25	Proposed Sale	7.41	27,000	200,041		Nov 07 04:14 PM
Bartholdson John A.	Director	Jun 06 '25	Option Exercise	0.00	7,575	0	79,620	Jun 10 05:49 PM
Bartholdson John A.	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	72,045	Jun 05 09:22 AM
SUTTER MARTIN P	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	85,241	Jun 04 09:30 PM
STALNECKER SUSAN M	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	105,957	Jun 04 09:30 PM
NOHRA GUY P	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	126,610	Jun 04 09:30 PM
NEELS GUIDO J	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	85,241	Jun 04 09:30 PM
McMurry-Heath Michelle	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	74,698	Jun 04 09:30 PM
Ladone Mary Kay	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	78,981	Jun 04 09:30 PM
HAWKINS WILLIAM A	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	257,851	Jun 04 09:29 PM
Beyer Pat	Director	Jun 02 '25	Option Exercise	0.00	26,493	0	76,436	Jun 04 09:29 PM
Singleton Mark Leonard	SVP & CFO	Apr 11 '25	Sale	7.57	3,875	29,334	141,088	Apr 15 05:50 PM
D'Adamio Anthony	SVP & General Counsel	Apr 11 '25	Sale	7.57	2,958	22,392	131,416	Apr 15 05:50 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Apr 11 '25	Sale	7.57	1,283	9,712	55,557	Apr 15 05:49 PM
D'Adamio Anthony	Officer	Apr 11 '25	Proposed Sale	9.51	4,000	38,040		Apr 11 05:39 PM
Singleton Mark Leonard	SVP & CFO	Apr 10 '25	Option Exercise	0.00	13,000	0	144,963	Apr 11 05:31 PM
D'Adamio Anthony	SVP & General Counsel	Apr 10 '25	Option Exercise	0.00	9,925	0	134,374	Apr 11 05:30 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Apr 10 '25	Option Exercise	0.00	4,300	0	56,840	Apr 11 05:30 PM
Singleton Mark Leonard	SVP & CFO	Mar 24 '25	Sale	9.79	5,479	53,639	131,963	Mar 25 05:37 PM
Singleton Mark Leonard	Officer	Mar 24 '25	Proposed Sale	9.80	12,000	117,600		Mar 24 04:50 PM
Singleton Mark Leonard	SVP & CFO	Mar 21 '25	Option Exercise	0.00	18,625	0	137,442	Mar 21 05:24 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Mar 17 '25	Sale	9.75	1,018	9,926	52,540	Mar 18 05:34 PM
D'Adamio Anthony	SVP & General Counsel	Mar 17 '25	Sale	9.75	2,615	25,496	124,449	Mar 18 05:33 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Mar 14 '25	Option Exercise	0.00	3,456	0	53,558	Mar 14 07:06 PM
D'Adamio Anthony	SVP & General Counsel	Mar 14 '25	Option Exercise	0.00	8,886	0	127,064	Mar 14 07:05 PM
Singleton Mark Leonard	SVP & CFO	Feb 18 '25	Sale	10.19	6,498	66,215	118,817	Feb 20 07:01 PM
D'Adamio Anthony	SVP & General Counsel	Feb 18 '25	Sale	10.19	4,380	44,632	118,178	Feb 20 07:00 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Feb 18 '25	Sale	10.19	1,537	15,662	50,102	Feb 20 07:00 PM
Singleton Mark Leonard	SVP & CFO	Feb 15 '25	Option Exercise	0.00	20,153	0	125,315	Feb 18 06:00 PM
D'Adamio Anthony	SVP & General Counsel	Feb 15 '25	Option Exercise	0.00	12,980	0	122,558	Feb 18 06:00 PM
CHURCH KATRINA J	SVP & Chief Compliance Officer	Feb 15 '25	Option Exercise	0.00	4,375	0	51,639	Feb 18 05:59 PM

Open in Screener

LDOS

Leidos Holdings Inc

Feb 12 • 12:37PM ET

170.63

-2.37 -1.37 %

Technology • Information Technology Services • USA • NYSE

LDOS Leidos Holdings Inc daily Stock Chart

Peers: SAIC BAH CACI GD LMT RTX NOC HII BA

| Held by: VTI VOO CIBR IVV SPY VB VO SHLD RSP VBR

Index	S&P 500	P/E	15.92	EPS (ttm)	10.72	Insider Own	0.84%	Shs Outstand	127.85M	Perf Week	-8.30%
Market Cap	21.82B	Forward P/E	13.85	EPS next Y	12.32	Insider Trans	-3.99%	Shs Float	126.78M	Perf Month	-12.92%
Enterprise Value	25.99B	PEG	1.75	EPS next Q	2.61	Inst Own	78.64%	Short Float	2.12%	Perf Quarter	-13.93%
Income	1.41B	P/S	1.26	EPS this Y	15.98%	Inst Trans	-1.71%	Short Ratio	3.14	Perf Half Y	-6.22%
Sales	17.33B	P/B	4.44	EPS next Y	4.02%	ROA	10.45%	Short Interest	2.69M	Perf YTD	-5.41%
Book/sh	38.40	P/C	19.89	EPS next 5Y	7.90%	ROE	29.51%	52W High	205.77 -17.07%	Perf Year	24.69%
Cash/sh	8.58	P/FCF	15.74	EPS past 3/5Y	20.53% 14.92%	ROIC	13.88%	52W Low	123.62 38.03%	Perf 3Y	69.25%
Dividend Est.	1.62 (0.95%)	EV/EBITDA	11.13	Sales past 3/5Y	6.65% 8.47%	Gross Margin	17.61%	Volatility	4.89% 3.16%	Perf 5Y	58.29%
Dividend TTM	1.63 (0.96%)	EV/Sales	1.50	EPS Y/Y TTM	22.17%	Oper. Margin	11.78%	ATR (14)	6.56	Perf 10Y	452.83%
Dividend Ex-Date	Dec 15, 2025	Quick Ratio	1.50	Sales Y/Y TTM	6.48%	Profit Margin	8.11%	RSI (14)	30.24	Recom	1.94
Dividend Gr. 3/5Y	3.23% 3.13%	Current Ratio	1.62	EPS Q/Q	5.48%	SMA20	-9.57%	Beta	0.63	Target Price	219.31
Payout	16.70%	Debt/Eq	1.07	Sales Q/Q	6.66%	SMA50	-9.49%	Rel Volume	1.27	Prev Close	173.00
Employees	48000	LT Debt/Eq	1.06	Earnings	Feb 17 BMO	SMA200	-3.30%	Avg Volume	854.96K	Price	170.63
IPO	Oct 13, 2006	Option/Short	Yes / Yes	EPS/Sales Surpr.	12.35% 4.49%	Trades		Volume	549,056	Change	-1.37%

Date	Action	Analyst	Rating Change	Price Target Change
Jan-08-26	Downgrade	Stifel	Buy → Hold	$220
Dec-12-25	Initiated	Citigroup	Buy	$218
Sep-04-25	Upgrade	RBC Capital Mkts	Sector Perform → Outperform	$210
Aug-06-25	Upgrade	Jefferies	Hold → Buy	$205
Jun-24-25	Resumed	Stifel	Buy	$178
May-27-25	Downgrade	Robert W. Baird	Outperform → Neutral	$163
Feb-21-25	Downgrade	William Blair	Outperform → Mkt Perform
Feb-07-25	Initiated	Cantor Fitzgerald	Overweight	$185
Jan-08-25	Downgrade	TD Cowen	Buy → Hold	$200 → $165
Dec-12-24	Downgrade	Goldman	Buy → Neutral	$228 → $153
Dec-02-24	Initiated	UBS	Neutral	$182
Jan-05-24	Upgrade	Barclays	Equal Weight → Overweight
Nov-17-23	Upgrade	Argus	Hold → Buy
May-25-23	Upgrade	Wells Fargo	Equal Weight → Overweight	$87 → $102
Mar-27-23	Downgrade	Jefferies	Buy → Hold	$120 → $95
Dec-08-22	Initiated	Citigroup	Buy	$130
Aug-30-22	Initiated	RBC Capital Mkts	Sector Perform	$106
Jun-07-22	Downgrade	Barclays	Overweight → Equal Weight	$105
Mar-24-22	Downgrade	Wells Fargo	Overweight → Equal Weight	$97 → $113
Mar-18-22	Resumed	Stifel	Buy	$126

Show Previous Ratings

Today 08:00AM	Leidos to launch next phase of DODNet transformation through accelerated migration of defense agencies (PR Newswire)
Feb-11-26 05:45PM	Leidos (LDOS) Suffers a Larger Drop Than the General Market: Key Insights (Zacks) -11.15%
09:15AM	Unveiling Leidos (LDOS) Q4 Outlook: Wall Street Estimates for Key Metrics (Zacks)
08:00AM	Leidos to participate in the Citi 2026 Global Industrial Tech and Mobility Conference (PR Newswire)
Feb-10-26 10:00AM	Leidos (LDOS) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
08:00AM	Loading…
Feb-09-26 08:00AM	Leidos enhancing information sharing, decision making across U.S. security agencies (PR Newswire)
Feb-05-26 08:00AM	Leidos, RegScale to improve digital security for Department of War and federal agencies (PR Newswire)
Feb-04-26 09:00AM	Leidos and Trustible Launch Joint Initiative to Redefine AI Governance with Agents (PR Newswire)
Feb-03-26 05:25PM	Jack Henry (JKHY) Q2 Earnings and Revenues Top Estimates (Zacks)
08:41AM	Is Delivery Volume Growth Showing Strong Adoption for Serve Robotics? (Zacks)
Feb-02-26 09:25AM	Why Smart Money Is Chasing This Defense Tech Shift (PR Newswire)
Feb-01-26 04:38AM	Leidos to Buy ENTRUST for $2.4B Cash Deal, Aiming to Turbocharge Energy Growth by 2026 (MarketBeat)
Jan-30-26 04:53PM	Deal Dispatch: Musk Merger Talk, LIV Golf Stakes, And A Flurry Of M&A From AI To Athleisure (Benzinga)
10:19AM	Leidos Expands Energy Infrastructure Presence With $2.4B ENTRUST Deal (Zacks)
Jan-29-26 12:10PM	Trump's Race to Space Superiority: 2 Rocket Stocks Ready to Take Off in 2026 (Motley Fool)
09:50AM	Loading…
09:50AM	Why Leidos (LDOS) is a Top Momentum Stock for the Long-Term (Zacks)
09:00AM	Is Trending Stock Leidos Holdings, Inc. (LDOS) a Buy Now? (Zacks)
08:55AM	Looking for Stocks with Positive Earnings Momentum? Check Out These 2 Computer and Technology Names (Zacks)
06:06AM	Wix.com (WIX) Soars 5.8%: Is Further Upside Left in the Stock? (Zacks)
Jan-28-26 11:35AM	Implied Volatility Surging for Leidos Stock Options (Zacks)
09:40AM	Why Leidos (LDOS) is a Top Value Stock for the Long-Term (Zacks)
Jan-27-26 05:50PM	Leidos (LDOS) Stock Sinks As Market Gains: Here's Why (Zacks)
02:12PM	Neuberger Berman Capital Solutions Exits Minority Investment in ENTRUST Solutions Group Through Sale to Leidos for $2.4 Billion (PR Newswire)
06:26AM	Leidos signs agreement to acquire ENTRUST Solutions in $2.4bn deal (Power Technology)
Jan-26-26 09:15AM	Market Minute 1-26-26- Gold Tops $5K as US Dollar Slides (MoneyShow)
09:00AM	Next-Generation RF Systems Move to the Center of Global Defense Spending (PR Newswire)
08:30AM	Leidos Buys ENTRUST In $2.4 Billion Power Infrastructure Bet (Benzinga)
06:55AM	Leidos to Buy Kohlberg's Entrust for $2.4 Billion (The Wall Street Journal)
06:24AM	Leidos to buy power design firm ENTRUST for about $2.4 billion (Reuters)
06:15AM	Kohlberg Announces Sale of ENTRUST Solutions Group to Leidos for $2.4 Billion (Business Wire)
06:01AM	Loading…
06:01AM	Leidos to acquire power design firm ENTRUST, bolstering its energy infrastructure portfolio (PR Newswire)
Jan-24-26 06:20AM	President Trump Might Ban Defense Contractor Dividends. What Does That Mean for Investors? (Motley Fool)
06:05AM	Here's What TD Cowen Thinks About Leidos Holdings (LDOS) (Insider Monkey)
Jan-23-26 08:43AM	Leidos Partners With OpenAI to Deploy AI Solutions Across Sectors (Zacks)
Jan-22-26 03:55PM	Leidos, OpenAI Team Up to Build AI for Federal Agencies (The Wall Street Journal)
03:00PM	Leidos, OpenAI deploying AI to transform federal operations (PR Newswire)
Jan-21-26 08:23AM	Defense Spending Is Rising-Here Are 3 Stocks Built for Turbulent Times (MarketBeat)
Jan-20-26 06:00PM	Leidos (LDOS) Stock Moves -1.94%: What You Should Know (Zacks)
Jan-19-26 04:41AM	What You Need To Know Ahead of Leidos Holdings Earnings Release (Barchart)
Jan-16-26 12:17PM	Can Serve Robotics Translate Lower Robot Costs Into Margin Leverage? (Zacks)
08:05AM	Leidos price target lowered to $204 from $216 at UBS (TipRanks)
Jan-14-26 08:58AM	HII's UK Facility Expansion Boosts Unmanned Systems Presence in Europe (Zacks)
Jan-13-26 10:56AM	Is Agentic Process Automation a Lever for Operating Leverage at C3.ai? (Zacks)
09:50AM	Here's Why Leidos (LDOS) is a Strong Momentum Stock (Zacks)
08:55AM	These 2 Computer and Technology Stocks Could Beat Earnings: Why They Should Be on Your Radar (Zacks)
08:00AM	Leidos Schedules Fourth Quarter and Full Year 2025 Earnings Conference Call for February 17, 2026, at 8 a.m. (ET) (PR Newswire)
Jan-12-26 05:50PM	Leidos (LDOS) Stock Slides as Market Rises: Facts to Know Before You Trade (Zacks)
12:10PM	Why Leidos (LDOS) is Poised to Beat Earnings Estimates Again (Zacks)
09:40AM	Here's Why Leidos (LDOS) is a Strong Value Stock (Zacks)
Jan-08-26 01:37PM	Final Trades: Morgan Stanley, Leidos Holdings, Enterprise Products and Amazon (CNBC TV)
09:30AM	Wall Street Bulls Look Optimistic About Leidos (LDOS): Should You Buy? (Zacks)
Jan-07-26 11:40AM	LDOS or NOW: Which Is the Better Value Stock Right Now? (Zacks)
08:19AM	BigBear.ai Trading at 16X P/S: Is the Premium Fully Earned? (Zacks)
Jan-06-26 05:50PM	Leidos (LDOS) Exceeds Market Returns: Some Facts to Consider (Zacks)
11:40AM	LDOS vs. NOW: Which Stock Is the Better Value Option? (Zacks)
08:47AM	Buy 5 High-Flying Old Economy Stocks of 2025 for Solid Near-Term Gains (Zacks)
08:30AM	Here's How Much a $1000 Investment in Leidos Made 10 Years Ago Would Be Worth Today (Zacks)
Jan-05-26 03:45PM	Why Leidos (LDOS) Stock Is Up Today (StockStory) +6.55%
Dec-30-25 11:03PM	2 Reasons to Like LDOS (and 1 Not So Much) (StockStory)
05:45PM	Why Leidos (LDOS) Dipped More Than Broader Market Today (Zacks)
Dec-26-25 09:10AM	China Sanctions U.S. Defense Companies Northrop Grumman, Boeing, Anduril (Investor's Business Daily)
Dec-22-25 11:52AM	C3.ai Doubles Down on Federal AI: Can Execution Catch Up? (Zacks)
Dec-18-25 11:40AM	LDOS or NOW: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Leidos (LDOS) Stock Outpacing Its Computer and Technology Peers This Year? (Zacks)
Dec-17-25 09:40AM	Why This 1 Value Stock Could Be a Great Addition to Your Portfolio (Zacks)
09:23AM	Can BigBear.ai's Agentic AI Lead the Next Wave of Defense Automation? (Zacks)
Dec-16-25 10:49AM	Can SERV's Rapid Fleet Expansion Drive a Step-Change in Revenue Growth? (Zacks)
04:14AM	Zacks.com featured highlights include TE Connectivity, Enersys, Donaldson, Lam Research and Leidos (Zacks)
Dec-15-25 09:29AM	Buy These 5 Dividend Growth Stocks Amid Heavy Tech Sell-Offs (Zacks)
08:45AM	Leidos taps leading AI tech executive Ted Tanner as chief technology officer (PR Newswire)
Dec-11-25 04:33AM	How Is Leidos Holdings Stock Performance Compared to Other Tech Stocks? (Barchart)
Dec-09-25 08:32AM	SERV's Restaurant Network Scales Up: Can It Drive a New Growth Cycle? (Zacks)
Dec-08-25 08:00AM	Leidos and CargoSeer collaborate to optimize customs checkpoint inspections (PR Newswire)
Dec-06-25 06:26AM	The Starlab Space Station Team Just Keeps Growing (Motley Fool)
Dec-04-25 04:01PM	Leidos to continue as program administrator for Hawai'i Energy (PR Newswire)
12:04PM	BAE Systems Rolls Out Velhawk to Expand Cybersecurity Capabilities (Zacks)
11:30AM	Leidos (LDOS) Down 3.4% Since Last Earnings Report: Can It Rebound? (Zacks)
Dec-03-25 08:39AM	BigBear.ai Stock Rises 36% in 6 Months: Is It Still a Buy? (Zacks)
Dec-02-25 11:40AM	LDOS or EXLS: Which Is the Better Value Stock Right Now? (Zacks)
09:40AM	Is Leidos (LDOS) Outperforming Other Computer and Technology Stocks This Year? (Zacks)
08:00AM	Leidos explosive trace detection system achieves latest EU security standard (PR Newswire)
Dec-01-25 12:00PM	Leidos (LDOS) Upgraded to Buy: What Does It Mean for the Stock? (Zacks)
09:30AM	Wall Street Analysts Think Leidos (LDOS) Is a Good Investment: Is It? (Zacks)
Nov-28-25 09:00AM	Is Most-Watched Stock Leidos Holdings, Inc. (LDOS) Worth Betting on Now? (Zacks)
Nov-27-25 01:14PM	BigBear.ai vs. Leidos: Which Defense-Focused AI Stock Should You Buy? (Zacks)
09:50AM	Why Leidos (LDOS) is a Top Momentum Stock for the Long-Term (Zacks)
Nov-26-25 09:40AM	Leidos (LDOS) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Nov-25-25 10:32PM	Defense Contractors Stocks Q3 In Review: Leidos (NYSE:LDOS) Vs Peers (StockStory)
08:00AM	Leidos and Quadridox partner to make baggage screening more accurate and efficient (PR Newswire)
Nov-24-25 07:24AM	Leidos Holdings Stock: Analyst Estimates & Ratings (Barchart)
Nov-21-25 02:11PM	Final Trades: Vistra, Leidos Holdings, Walmart and Zoom Communications (CNBC TV)
Nov-18-25 08:00AM	Leidos to participate in the Goldman Sachs Industrials and Materials Conference (PR Newswire)
Nov-15-25 07:07AM	The Starlab International Space Station Just Added a Big U.S. Defense Contractor to Its Team (Motley Fool)
Nov-12-25 09:52AM	BigBear.ai's Ask Sage Buyout: Can it Become a GenAI Powerhouse? (Zacks)
Nov-06-25 08:19AM	BigBear.ai Before Q3 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Nov-05-25 09:50AM	Here's Why Leidos (LDOS) is a Strong Momentum Stock (Zacks)
07:52AM	Starlab Names Leidos as Primary Assembly, Integration and Testing Provider (Business Wire)
05:20AM	Company News for Nov 5, 2025 (Zacks)
Nov-04-25 04:02PM	Leidos Holdings Inc (LDOS) Q3 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
01:02PM	Leidos Holdings Beats Q3 Earnings Estimates, Raises '25 View (Zacks)

Leidos Holdings, Inc. engages in providing services and solutions in the defense, intelligence, civil and health markets. It operates through the following three segments: Defense Solutions, Civil, and Health. The Defense Solutions segment provides services, solutions, and products focusing on digital modernization, mission systems and integration, command, control, computers, communications, intelligence, surveillance and reconnaissance technologies and services, maritime solutions, transformative software, analytics, intelligence analysis, mission support and logistics services, weapons systems and space systems and solutions. The Civil segment focuses on modernizing infrastructure, systems, and security. The Health segment offers solutions to federal and commercial customers that are responsible for the health and wellbeing of people worldwide including service members and veterans. The company was founded by John Robert Beyster on February 3, 1969 and is headquartered in Reston, VA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Porter Elizabeth A	Sector President	Jan 20 '26	Sale	192.21	3,000	576,635	38,575	Jan 22 04:52 PM
Porter Elizabeth A	President, Health and Civil S	Jan 20 '26	Proposed Sale	194.70	3,000	584,100		Jan 20 10:43 AM
Porter Elizabeth A	Sector President	Dec 19 '25	Sale	181.04	3,000	543,130	41,575	Dec 22 04:31 PM
Porter Elizabeth A	Officer	Dec 19 '25	Proposed Sale	181.36	3,000	544,080		Dec 19 09:38 AM
Hull Stephen Edward	Sector President	Sep 02 '25	Option Exercise	96.56	11,526	1,112,928	37,896	Sep 04 05:18 PM
Hull Stephen Edward	Sector President	Sep 04 '25	Option Exercise	129.79	2,827	366,916	40,723	Sep 04 05:18 PM
Hull Stephen Edward	Sector President	Sep 04 '25	Sale	178.14	12,497	2,226,216	25,817	Sep 04 05:18 PM
Hull Stephen Edward	Sector President	Sep 04 '25	Proposed Sale	178.25	12,497	2,227,590		Sep 04 12:49 PM
Geer Noel B	Director	Aug 27 '25	Option Exercise	75.02	3,345	250,942	37,019	Aug 29 04:35 PM
Stevens Roy E	Sector President	Aug 25 '25	Option Exercise	62.43	7,536	470,472	57,470	Aug 27 04:15 PM
Stevens Roy E	Sector President	Aug 25 '25	Sale	181.66	2,716	493,398	49,934	Aug 27 04:15 PM
Stevens Roy E	Sector President	Aug 25 '25	Proposed Sale	181.66	2,750	499,574		Aug 25 03:24 PM
Hull Stephen Edward	Sector President	Aug 20 '25	Sale	178.27	12,890	2,297,945	26,370	Aug 22 04:09 PM
Hull Stephen Edward	Sector President	Aug 20 '25	Proposed Sale	178.77	12,890	2,304,345		Aug 20 12:02 PM
Hull Stephen Edward	Sector President	Aug 15 '25	Option Exercise	84.42	12,779	1,078,832	39,260	Aug 19 04:30 PM
May Gary Stephen	Director	Aug 11 '25	Sale	178.05	2,000	356,104	10,137	Aug 13 05:54 PM
Dahlberg Gregory R	Director	Aug 11 '25	Option Exercise	119.50	2,948	352,278	24,016	Aug 13 05:50 PM
Dahlberg Gregory R	Director	Aug 11 '25	Sale	177.43	952	168,911	21,068	Aug 13 05:50 PM
Hull Stephen Edward	Sector President	Aug 08 '25	Sale	176.39	7,526	1,327,477	26,481	Aug 12 04:35 PM
Dahlberg Gregory R	Director	Aug 11 '25	Proposed Sale	177.43	952	168,911		Aug 11 03:58 PM
May Gary Stephen	Director	Aug 11 '25	Proposed Sale	178.05	2,000	356,104		Aug 11 10:59 AM
Hull Stephen Edward	Officer	Aug 08 '25	Proposed Sale	176.22	7,526	1,326,232		Aug 08 11:45 AM
Dahlberg Gregory R	Director	May 09 '25	Sale	154.55	1,250	193,190	20,195	May 09 04:12 PM
Dahlberg Gregory R	Director	May 09 '25	Proposed Sale	154.55	1,250	193,190		May 09 11:58 AM
Kovarik Robert C JR	Director	May 08 '25	Proposed Sale	154.73	2,486	384,669		May 08 01:05 PM
Schmanske Mary Vicki	Sector President	Mar 13 '25	Option Exercise	89.24	55,508	4,953,361	118,588	Mar 17 05:05 PM
Fasano Gerard A	Chief Growth Officer	Mar 10 '25	Option Exercise	129.79	2,860	371,199	101,619	Mar 11 05:29 PM
Fasano Gerard A	Chief Growth Officer	Mar 06 '25	Option Exercise	96.63	8,964	866,168	106,820	Mar 10 04:36 PM
SHAPARD ROBERT S	Director	Feb 25 '25	Option Exercise	63.08	4,070	256,736	58,207	Feb 27 04:46 PM
KRAEMER HARRY M JANSEN JR	Director	Feb 21 '25	Option Exercise	63.08	4,070	256,736	91,360	Feb 25 05:16 PM
STALNECKER SUSAN M	Director	Feb 18 '25	Option Exercise	80.48	13,603	1,094,757	29,263	Feb 19 04:32 PM
Porter Elizabeth A	Sector President	Feb 18 '25	Option Exercise	63.76	2,524	160,930	44,581	Feb 19 04:31 PM
May Gary Stephen	Director	Feb 18 '25	Option Exercise	63.08	4,070	256,736	15,334	Feb 19 04:30 PM
May Gary Stephen	Director	Feb 18 '25	Sale	131.24	2,128	279,279	11,264	Feb 19 04:30 PM
Hull Stephen Edward	Sector President	Feb 14 '25	Option Exercise	63.76	2,589	165,075	32,993	Feb 19 04:28 PM
May Gary Stephen	Director	Feb 18 '25	Proposed Sale	131.24	2,128	279,269		Feb 18 02:00 PM
Kovarik Robert C JR	Director	Feb 13 '25	Option Exercise	75.02	3,345	250,942	9,753	Feb 14 04:33 PM
Kovarik Robert C JR	Director	Feb 13 '25	Sale	134.56	1,511	203,322	6,408	Feb 14 04:33 PM
Dahlberg Gregory R	Director	Feb 13 '25	Option Exercise	63.08	3,070	193,656	22,861	Feb 14 04:32 PM
Cage Christopher R	Chief Financial Officer	Feb 13 '25	Option Exercise	63.76	2,419	154,235	46,738	Feb 14 04:30 PM
Kovarik Robert C JR	Director	Feb 13 '25	Proposed Sale	134.56	1,511	203,322		Feb 13 10:50 AM

BVS

Bioventus Inc

LDOS

Leidos Holdings Inc

Upgrade your FINVIZ experience